Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab.
MS Research Roundup: January 18, 2015
Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis?
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies - Trends and Future Opportunities.
Boosting CNS axon regeneration by circumventing limitations of natural cytokine signaling.
Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Multiple sclerosis: Bigger brains resist disability in MS.
MS Research Roundup: June 4, 2014
MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Construct Validity of the Four Square Step Test in Multiple Sclerosis.
MS Research Roundup: August 18, 2014
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis.
The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.
[The biological role of sulfatides].
Novel Insights into the Multiple Sclerosis Risk Gene ANKRD55.
Sodium intake is associated with increased disease activity in multiple sclerosis.
Co-occurrence of multiple sclerosis and Parkinson disease.

Pages